The DOI matches its Crossref record; 333 of the 333 references it cites were found in a registry or an index.
Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–333 of 333
Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis
James, C., Delhommeau, F., Marzac, C., Teyssandier, I., Couédic, J. L., Giraudier, S., Roy, L., Saulnier, P., Lacroix, L., Maury, S., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404069 · Cited by 144
JAK-STAT signaling activated by Abl oncogenes
Danial, N. N., & Rothman, P. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203484 · Cited by 143
Sun, H., King, A. J., Diaz, H. B., & Marshall, M. S. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00359-6 · Cited by 141
Wang, C.-Y., Bassuk, A. G., Boise, L., Thompson, C. B., Bravo, R., & Leiden, J. M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.1153-1159.1994 · Cited by 140
Coutant, A., Rescan, C., Gilot, D., Loyer, P., Guguen‐Guillouzo, C., & Baffet, G. (2002) · Hepatology · doi:10.1053/jhep.2002.36160 · Cited by 135
de Toni, F., Racaud‐Sultan, C., Chicanne, G., Mas, V. M., Cariven, C., Briand‐Mésange, F., Salles, J., Demur, C., Allouche, M., Payrastre, B., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1209346 · Cited by 134
Romana, S. P., Radford‐Weiss, I., Abdelali, R. B., Schluth‐Bolard, C., Petit, A., Dastugue, N., Talmant, P., Bilhou‐Nabera, C., Mugneret, F., Lafage‐Pochitaloff, M., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404130 · Cited by 133
Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma
Feilotter, H. E., Coulon, V., McVeigh, J. L., Boag, A. H., Dorion-Bonnet, F., Duboué, B., Latham, W. C. W., Eng, C., Mulligan, L. M., & Longy, M. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690115 · Cited by 133
Martelli, A. M., Faenza, I., Billi, A. M., Manzoli, L., Evangelisti, C., Falà, F., & Cocco, L. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.01.011 · Cited by 131
Self-citationRedox Regulation of the Calcium/Calmodulin-dependent Protein Kinases
Howe, C. J., LaHair, M. M., McCubrey, J. A., & Franklin, R. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404175200 · Cited by 130
Self-citationTauchi, T., Boswell, H. S., Leibowitz, D. S., & Broxmeyer, H. E. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.1.167 · Cited by 129
The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia
Mikesch, J.-H., Steffen, B., Berdel, W. E., Serve, H. L., & Müller‐Tidow, C. (2007) · Leukemia · doi:10.1038/sj.leu.2404732 · Cited by 128
Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia
Luo, J.-M., Yoshida, H., Komura, S., Ohishi, N., Pan, L., Shigeno, K., Hanamura, I., Miura, K., Iida, S., Ueda, R., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2402725 · Cited by 127
Shih, L.-Y., Liang, D.-C., Fu, J., Jh, W., Wang, P.-N., Lin, T.-L., Dunn, P., Kuo, M.-C., Tang, T., Lin, T.-H., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2404024 · Cited by 127
Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt.
Majewski, M., Nieborowska-Skorska, M., Salomoni, P., Słupianek, A., Reiss, K., Trotta, R., Calabretta, B., & Skórski, T. (1999) · PubMed · Cited by 126
Ricciardi, M. R., McQueen, T. J., Chism, D. D., Milella, M., Estey, E. H., Kaldjian, E. P., Sebolt, J. S., Konopleva, M. Y., & Andreeff, M. (2005) · Leukemia · doi:10.1038/sj.leu.2403859 · Cited by 125
Self-citationOakes, S. A., Candotti, F., Johnston, J. A., Chen, Y., RYAN, J., Taylor, N. N., Liu, X., Hennighausen, L. G., Notarangelo, L. D., Paul, W. E., et al. (1996) · Immunity · doi:10.1016/s1074-7613(00)80274-5 · Cited by 125
Christiansen, D. H., Andersen, M. K., Desta, F. Z., & Pedersen-Bjergaard, J. (2005) · Leukemia · doi:10.1038/sj.leu.2404009 · Cited by 121
Speleman, F., Cauwelier, B., Dastugue, N., Cools, J., Verhasselt, B., Poppe, B. G., Roy, N. V., Vandesompele, J., Graux, C., Uyttebroeck, A., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2403657 · Cited by 121
Shishodia, S., & Aggarwal, B. B. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/1-4020-7847-1_8 · Cited by 121
BH3-only proteins in control: specificity regulates MCL-1 and BAK-mediated apoptosis: Figure 1.Preprint
Gélinas, C., & White, E. (2005) · Genes & Development · doi:10.1101/gad.1326205 · Cited by 120
Role of Bim in the survival pathway induced by Raf in epithelial cells
Marani, M., Hancock, D. C., Lopes, R., Tenev, T., Downward, J., & Lemoine, N. R. (2003) · Oncogene · doi:10.1038/sj.onc.1207364 · Cited by 115
Martelli, A. M., Tazzari, P. L., Evangelisti, C., Chiarini, F., Blalock, W. L., Billi, A. M., Manzoli, L., McCubrey, J. A., & Cocco, L. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707781368423 · Cited by 114
Self-citationAbnormalities at 14q32.1 in T cell malignancies involve two oncogenes
Pekarsky, Y., Hallas, C., Isobe, M., Russo, G., & Croce, C. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2949 · Cited by 108
Regulation and targeting of antiapoptotic XIAP in acute myeloid leukemia
Carter, B. Z., Milella, M., Tsao, T., McQueen, T. J., Schober, W. D., Hu, W., Dean, N. M., Steelman, L. S., McCubrey, J. A., & Andreeff, M. (2003) · Leukemia · doi:10.1038/sj.leu.2403113 · Cited by 107
Self-citationPhosphoinositide 3-kinases as drug targets in cancer
Stephens, L., WILLIAMS, R., & Hawkins, P. T. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.03.002 · Cited by 106
Lanfrancone, L., Pelicci, P. G., Brizzi, M. F., Aronica, M. G., Casciari, C., Giuli, S., Pegoraro, L., Pawson, T. J., Pelicci, P. G., & Arouica, M. G. (1995) · PubMed · Cited by 103
Serum- and Glucocorticoid-inducible Kinase SGK Phosphorylates and Negatively Regulates B-Raf
Zhang, B.-H., Tang, E., Zhu, T., Greenberg, M. E., Vojtek, A. B., & Guan, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102808200 · Cited by 103
Muraille, É., Pesesse, X., KUNTZ, C., & Erneux, C. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3420697 · Cited by 103
Mahimainathan, L., & Choudhury, G. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314328200 · Cited by 103
Regulation of Bcl2 Phosphorylation and Potential Significance for Leukemic Cell Chemoresistance
Deng, X., Kornblau, S. M., Ruvolo, P. P., & May, W. S. (2000) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024254 · Cited by 103
The complexity of PTEN: mutation, marker and potential target for therapeutic intervention
Steelman, L. S., Bertrand, F. E., & McCubrey, J. A. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.6.537 · Cited by 102
Self-citationTsutsui, S., Inoue, H., Yasuda, K., Suzuki, K., Higashi, H., Era, S., & Mori, M. (2005) · Oncology · doi:10.1159/000086981 · Cited by 101
Lindeman, G. J., Wittlin, S., Lada, H., Naylor, M. J., Santamaria, M., Zhang, J., Starr, R., Hilton, D. J., Alexander, W. S., Ormandy, C. J., et al. (2001) · Genes & Development · doi:10.1101/gad.880801 · Cited by 101
Analysis of BRAF Mutation in Primary and Metastatic Melanoma
Libra, M., Malaponte, G., Navolanic, P. M., et al. (2005) · Cell Cycle · doi:10.4161/cc.4.10.2026 · Cited by 100
Self-citationNyåkern, M., Tazzari, P. L., Finelli, C., Bosi, C., Follo, M. Y., Grafone, T., Piccaluga, P. P., Martinelli, G., Cocco, L., & Martelli, A. M. (2005) · Leukemia · doi:10.1038/sj.leu.2404057 · Cited by 99
Self-citationLiu, Y., Chen, L., Ko, T. C., Fields, A. P., & Thompson, E. A. (2006) · Oncogene · doi:10.1038/sj.onc.1209403 · Cited by 98
McCubrey, J. A., Steelman, L., Hoyle, P., Blalock, W. L., Oppenheimer, C. W., Franklin, R. A., Cherwinski, H. M., Bosch, E., & McMahon, M. (1998) · Leukemia · doi:10.1038/sj.leu.2401215 · Cited by 98
Self-citationPane, F., Cimino, G. G., Izzo, B., Camera, A., Vitale, A., Quintarelli, C., Picardi, M., Specchia, G., Mancini, M., Cuneo, A., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2403683 · Cited by 97
Antiestrogen-resistant human breast cancer cells require activated Protein Kinase B/Akt for growth
Frogne, T., Jepsen, J. S., Larsen, S. S., Fog, C. K., Brockdorff, B. L., & Lykkesfeldt, A. E. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.00946 · Cited by 95
Tanuma, N., Nakamura, K., Shima, H., & Kikuchi, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003661200 · Cited by 95
Novel targets of Akt, p21, and MDM2
Zhou, B. P., & Hung, M. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70128-0 · Cited by 94
Identification of Akt Association and Oligomerization Domains of the Akt Kinase Coactivator TCL1
Künstle, G., Laine, J. T., Pierron, G., Kagami, S., Nakajima, H., Hoh, F., Roumestand, C., Stern, M., & Noguchi, M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.5.1513-1525.2002 · Cited by 94
Fusion of the ets Transcription Factor TEL to Jak2 Results in Constitutive Jak-Stat Signaling
Ho, J. M.-Y., Beattie, B. K., Squire, J. A., Frank, D. A., & Barber, D. L. (1999) · Blood · doi:10.1182/blood.v93.12.4354 · Cited by 94
B- and C-RAF Display Essential Differences in Their Binding to Ras
Fischer, A., Hekman, M., Kuhlmann, J., Rubio, I., Wiese, S., & Rapp, U. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607458200 · Cited by 91
An activated mTOR mutant supports growth factor-independent, nutrient-dependent cell survival
Edinger, A. L., & Thompson, C. B. (2004) · Oncogene · doi:10.1038/sj.onc.1207738 · Cited by 91
Zebisch, A., Staber, P. B., Delavar, A., Bodner, C., Hiden, K., Fischereder, K., Janakiraman, M., Linkesch, W., Auner, H. W., Emberger, W., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-0115 · Cited by 90
Nyåkern, M., Cappellini, A., Mantovani, I., & Martelli, A. M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0076 · Cited by 90
Self-citationThe MLL gene and translocations involving chromosomal band 11q23 in acute leukemia.
Braekeleer, M. D., Morel, F., Bris, M. L., Herry, A., & Douet‐Guilbert, N. (2005) · PubMed · Cited by 90
Hoyle, P., Moye, P. W., Steelman, L., Blalock, W. L., Franklin, R. A., Pearce, M., Cherwinski, H. M., Bosch, E., McMahon, M., & McCubrey, J. A. (2000) · Leukemia · doi:10.1038/sj.leu.2401720 · Cited by 89
Self-citationJücker, M., Südel, K. M., Horn, S., Sickel, M. J., Wegner, W., Fiedler, W., & Feldman, R. A. (2002) · Leukemia · doi:10.1038/sj.leu.2402484 · Cited by 87
Shelton, J. G., Steelman, L. S., Lee, J. T., Knapp, S. L., Blalock, W. L., Moye, P. W., Franklin, R. A., Pohnert, S. C., Mirza, A. M., McMahon, M., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206321 · Cited by 86
Self-citationILKAP regulates ILK signaling and inhibits anchorage-independent growth
Kumar, A. S., Naruszewicz, I., Wang, P., Leung-Hagesteijn, C., & Hannigan, G. E. (2004) · Oncogene · doi:10.1038/sj.onc.1207473 · Cited by 86
Jost, E., do Ó, N., Dahl, E., Maintz, C., Jousten, P., Habets, L., Wilop, S., Herman, J. G., Osieka, R., & Galm, O. (2007) · Leukemia · doi:10.1038/sj.leu.2404513 · Cited by 85
Jia, W., Yu, C., Rahmani, M., Krystal, G. W., Sausville, E. A., Dent, P., & Grant, S. (2003) · Blood · doi:10.1182/blood-2002-12-3785 · Cited by 84
Fornerod, M. W. J., Boer, J. M., van Baal, S., et al. (1996) · PubMed · Cited by 83
Cheong, J., Eom, J.-I., Maeng, H. M., Lee, S., Hahn, J. S., Ko, Y. W., & Min, Y. H. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04452.x · Cited by 81
The role of Jak3 in lymphoid development, activation, and signaling
Thomis, D. C., & Berg, L. J. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80108-2 · Cited by 80
Müller, C. I., Miller, C. W., Hofmann, W.-K., Gross, M. E., Walsh, C., Kawamata, N., Luong, Q. T., & Koeffler, H. P. (2006) · Leukemia Research · doi:10.1016/j.leukres.2006.04.011 · Cited by 78
Overexpression of phosphatidylinositol 3-kinase in human lung cancer
Lin, X., Böhle, A., Dohrmann, P., Leuschner, I., Schulz, A., Kremer, B., & Fändrich, F. (2001) · Langenbeck s Archives of Surgery · doi:10.1007/s004230100203 · Cited by 77
Vannucchi, A. M., Pancrazzi, A., Bogani, C., Antonioli, E., & Guglielmelli, P. (2006) · Leukemia · doi:10.1038/sj.leu.2404209 · Cited by 76
Chronic myeloproliferative disorders: a tyrosine kinase tale
Keersmaecker, K. D., & Cools, J. (2006) · Leukemia · doi:10.1038/sj.leu.2404064 · Cited by 75
Transient and sustained ERK phosphorylation and nuclear translocation in growth control
Adachi, T., Kar, S., Wang, M., & Carr, B. I. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10124 · Cited by 75
Blalock, W. L., Pearce, M., Steelman, L. S., Franklin, R. A., McCarthy, S. A., Cherwinski, H. M., McMahon, M., & McCubrey, J. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203337 · Cited by 75
Self-citationWitzig, T. E., & Kaufmann, S. H. (2006) · Current Treatment Options in Oncology · doi:10.1007/s11864-006-0038-1 · Cited by 74
Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemia
Ritter, M., Kattmann, D., Teichler, S., Hartmann, O., Samuelsson, M., Burchert, A., Bach, J.-P., Kim, T. D., Berwanger, B., Thiede, C., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404093 · Cited by 71
Aberrant hematopoiesis in mice with inactivation of the gene encoding SOCS-1
Metcalf, D., Ws, A., Elefanty, A. G., Nicola, N. A., Hilton, D. J., Starr, R., Mifsud, S., & Rago, L. D. (1999) · Leukemia · doi:10.1038/sj.leu.2401440 · Cited by 71
Pike‐Overzet, K., de Ridder, D., Weerkamp, F., Baert, M. R. M., Verstegen, M. M. A., Brugman, M. H., Howe, S. J., Reinders, M. J. T., Thrasher, A. J., Wagemaker, G., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404563 · Cited by 70
Chow, S., Minden, M. D., & Hedley, D. W. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.05.002 · Cited by 70
Dickinson, E. (2006) · The FASEB Journal · doi:10.1096/fj.07-0101 · Cited by 70
Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders
Aggerholm, A., Grønbæk, K., Guldberg, P., & Hokland, P. (2000) · European Journal Of Haematology · doi:10.1034/j.1600-0609.2000.90181.x · Cited by 69
Mutational screen reveals a novel JAK2 mutation, L611S, in a child with acute lymphoblastic leukemia
Kratz, C., Böll, S., Kontny, U., Schrappe, M., Niemeyer, C. M., & Stanulla, M. (2005) · Leukemia · doi:10.1038/sj.leu.2404060 · Cited by 68
Proto‐oncogene TCL1: more than just a coactivator for Akt
Noguchi, M., Ropars, V., Roumestand, C., & Suizu, F. (2007) · The FASEB Journal · doi:10.1096/fj.06-7684com · Cited by 68
Taming the Hippo: Raf-1 Controls Apoptosis by Suppressing MST2/Hippo
O’Neill, E. E., & Kölch, W. (2005) · Cell Cycle · doi:10.4161/cc.4.3.1531 · Cited by 68
Gire, V., Marshall, C. J., & Wynford‐Thomas, D. (2000) · Oncogene · doi:10.1038/sj.onc.1203544 · Cited by 68
Raf and the road to cell survival: a tale of bad spells, ring bearers and detours
Troppmair, J., & Rapp, U. R. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00483-0 · Cited by 66
Jak2-Stat5 Interactions Analyzed in Yeast
Barahmand-Pour, F., Meinke, A. L., Groner, B., & Decker, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12567 · Cited by 64
Mahalingam, M., & Templeton, D. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.1.405 · Cited by 63
Tresini, M., Lorenzini, A., Frisoni, L., Allen, R. G., & Cristofalo, V. J. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5334 · Cited by 63
McCubrey, J. A., Lee, J. T., Steelman, L. S., Blalock, W. L., Moye, P. W., Chang, F., Pearce, M., Shelton, J. G., White, M. K., Franklin, R. A., et al. (2001) · PubMed · Cited by 62
Self-citationWeisser, M., Haferlach, C., Hiddemann, W., & Schnittger, S. (2007) · Leukemia · doi:10.1038/sj.leu.2404659 · Cited by 61
Eblen, S. T., Catling, A. D., Assanah, M. C., & Weber, M. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.1.249-259.2001 · Cited by 61
NUP98 Fusion in Human Leukemia: Dysregulation of the Nuclear Pore and Homeodomain Proteins
Nakamura, T. (2005) · International Journal of Hematology · doi:10.1532/ijh97.04160 · Cited by 60
Kubota, Y., Ohnishi, H., Kitanaka, A., Ishida, T., & Tanaka, T. (2004) · Leukemia · doi:10.1038/sj.leu.2403402 · Cited by 60
Howe, C. J., LaHair, M. M., Maxwell, J. A., Lee, J. T., Robinson, P. J., Rodriguez–Mora, O., McCubrey, J. A., & Franklin, R. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205036200 · Cited by 59
Self-citationInami, M., Inokuchi, K., Okabe, M., Kosaka, F., Mitamura, Y., Yamaguchi, H., & Dan, K. (2007) · Leukemia · doi:10.1038/sj.leu.2404591 · Cited by 58
Genomic Sequence, Organization, and Chromosomal Localization of HumanJAK3
Riedy, M. C., Dutra, A. S., Blake, T. B., Modi, W. S., Lal, B. K., Davis, J., Bosse, A., O’Shea, J. J., & Johnston, J. A. (1996) · Genomics · doi:10.1006/geno.1996.0520 · Cited by 57
Blalock, W. L., Navolanic, P. M., Steelman, L. S., Shelton, J. G., Moye, P. W., Lee, J. T., Franklin, R. A., Mirza, A. M., McMahon, M., White, M. K., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2402925 · Cited by 56
Self-citationDenaturing High-Performance Liquid Chromatography
Roti, G., Rosati, R., Bonasso, R., Gorello, P., Diverio, D., Martelli, M. F., Falini, B., & Mecucci, C. (2006) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2006.050098 · Cited by 55
Mammalian Sterile 20–Like Kinases in Tumor Suppression: An Emerging Pathway
O’Neill, E. E., Matallanas, D., & Kölch, W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1453 · Cited by 54
Prima, V., Gore, L., Caires, A., Boomer, T., Yoshinari, M., Imaizumi, M., Varella-Garcia, M., & Hunger, S. P. (2005) · Leukemia · doi:10.1038/sj.leu.2403684 · Cited by 54
Mutational analysis of the PTEN/MMAC1 gene in non-Hodgkin’s lymphoma
Nakahara, Y., Nagai, H., Kinoshita, T., Uchida, T., Hatano, S., Murate, T., & Saito, H. (1998) · Leukemia · doi:10.1038/sj.leu.2401099 · Cited by 54
Inhorn, R. C., Carlesso, N., Durstin, M., Frank, D. A., & Griffin, J. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8665 · Cited by 50
p70s6 kinase is a functional target of insulin activated Akt cell-survival signaling
Jonassen, A. K., Mjøs, O. D., & Sack, M. N. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.029 · Cited by 50
Auguin, D., Barthe, P., Royer, C. A., Stern, M., Noguchi, M., Arold, S. T., & Roumestand, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400364200 · Cited by 49
Mutation analysis of SHIP gene in acute leukemia.
Luo, J., Liu, Z., Hao, H.-L., Wang, F., Dong, Z.-R., & Ryuzo, O. (2004) · PubMed · Cited by 49
Ohyashiki, K., Aota, Y., Akahane, D., Gotoh, A., Miyazawa, K., Kimura, Y., & Ohyashiki, J. H. (2005) · Leukemia · doi:10.1038/sj.leu.2403989 · Cited by 48
Mantovani, I., Cappellini, A., Tazzari, P. L., Papa, V., Cocco, L., & Martelli, A. M. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20628 · Cited by 47
Self-citationShelton, J. G., Steelman, L. S., Abrams, S. L., Bertrand, F. E., Franklin, R. A., McMahon, M., & McCubrey, J. A. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.5.1009 · Cited by 47
Self-citationFalini, B., Bigerna, B., Pucciarini, A., Tiacci, E., Mecucci, C., Morris, S. W., Bolli, N., Rosati, R., Hanissian, S. H., Ma, Z., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2404068 · Cited by 47
Golub, T. R., Barker, G. F., Stegmaier, K., & Gilliland, D. G. (1997) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-60479-9_5 · Cited by 47
Arcinas, M., Heckman, C. A., Mehew, J. W., et al. (2001) · PubMed · Cited by 46
Rao, P., & Mufson, R. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.12.6886 · Cited by 46
K-Ras and H-Ras Activation Promote Distinct Consequences on Endometrial Cell Survival
Ninomiya, Y., Kato, K., Takahashi, A., Ueoka, Y., Kamikihara, T., Arima, T., Matsuda, T., Kato, H., Nishida, J.-I., & Wake, N. (2004) · Cancer Research · doi:10.1158/0008-5472.can-3487-2 · Cited by 44
Trubia, M., Albano, F., Cavazzini, F., Cambrin, G. R., Quarta, G., Fabbiano, F., Ciambelli, F., Magro, D., Hernández‐Rivas, J. M., Mancini, M., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2404020 · Cited by 42
Tibes, R., Kornblau, S. M., Qiu, Y., Mousses, S., Robbins, C. M., Moses, T. Y., & Carpten, J. D. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06920.x · Cited by 40
PIKE/nuclear PI 3‐kinase signaling in preventing programmed cell death
Ye, K. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20549 · Cited by 40
Zhang, B., Groffen, J., & Heisterkamp, N. (2007) · Leukemia · doi:10.1038/sj.leu.2404667 · Cited by 38
Martínez‐Lorenzo, M. J., Anel, A., Monleón, I., Sierra, J. J., Piñeiro, A., Naval, J., & Álava, M. A. (2000) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00142-9 · Cited by 37
Gu, J., Wang, Y., & Gu, X. (2002) · Journal of Molecular Evolution · doi:10.1007/s00239-001-0072-3 · Cited by 37
Mesa, R. A., Tefferi, A., Lasho, T., Loegering, D. A., McClure, R. F., Powell, H. L., Dai, N. T., Steensma, D. P., & Kaufmann, S. H. (2006) · Leukemia · doi:10.1038/sj.leu.2404338 · Cited by 36
JAK2 seems to be a typical cooperating mutation in therapy-related t(8;21)/ AML1-ETO-positive AML
Schnittger, S., Bacher, U., Kern, W., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404465 · Cited by 36
Role of CREB transcription factor in c-fos activation in natural killer cells
Ponti, C., Gibellini, D., Boin, F., Melloni, E., Manzoli, F. A., Cocco, L., Zauli, G., & Vitale, M. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(2002012)32:12<3358::aid-immu3358>3.0.co;2-8 · Cited by 35
Signaling Domains of the βc Chain of the GM‐CSF/IL‐3/IL‐5 Receptor
Okuda, K., Foster, R., & Griffin, J. D. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08474.x · Cited by 35
Shelton, J. G., Blalock, W. L., White, E. R., Steelman, L. S., & McCubrey, J. A. (2004) · Cell Cycle · doi:10.4161/cc.3.4.813 · Cited by 34
Self-citationTagliafico, E., Tenedini, E., Manfredini, R., Grande, A., Ferrari, F., Roncaglia, E., Bicciato, S., Zini, R., Salati, S., Bianchi, E., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404358 · Cited by 34
Lee, J. T., & McCubrey, J. A. (2002) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.6.6.659 · Cited by 33
Self-citationFusion tyrosine kinase mediated signalling pathways in the transformation of haematopoietic cells
Turner, S. D., & Alexander, D. R. (2006) · Leukemia · doi:10.1038/sj.leu.2404125 · Cited by 33
Mesa, R. A., Tefferi, A., Li, C.-Y., & Steensma, D. P. (2006) · Leukemia · doi:10.1038/sj.leu.2404398 · Cited by 32
Genomic acute myeloid leukemia-associated inv(16)(p13q22) breakpoints are tightly clustered
van der Reijden, B. A., Dauwerse, H. G., Giles, R. H., Jagmohan–Changur, S., Wijmenga, C., Liu, P. P., Smit, B., Wessels, H. W., Beverstock, G. C., Jotterand-Bellomo, M., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202321 · Cited by 29
Shikami, M., Miwa, H., Nishii, K., Takahashi, T., Shiku, H., Tsutani, H., Oka, K., Hamaguchi, H., Kyo, T., Tanaka, K. J., et al. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01384.x · Cited by 27
Shelton, J. G., Steelman, L. S., Abrams, S. L., White, E. R., Akula, S. M., Franklin, R. A., Bertrand, F. E., McMahon, M., & McCubrey, J. A. (2005) · Cell Cycle · doi:10.4161/cc.4.6.1724 · Cited by 27
Self-citationSequist, L. V. D., Haber, D. A., & Lynch, T. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1055 · Cited by 27
Synergistic effects of pi3k/akt on abrogation of cytokine-dependency induced by oncogenic raf
McCubrey, J. A., Steelman, L. S., Blalock, W. L., Lee, J. T., Moye, P. W., Chang, F., Pearce, M., Shelton, J. G., White, M. K., Franklin, R. A., et al. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00021-2 · Cited by 26
Self-citationNuclear diacylglycerol kinases: emerging downstream regulators in cell signaling networks.
Evangelisti, C., Bortul, R., Falà, F., Tabellini, G., Goto, K., & Martelli, A. M. (2007) · PubMed · doi:10.14670/hh-22.573 · Cited by 25
Self-citationBellosillo, B., Martinez-Aviles, L. M., Gimeno, E., Florensa, L., Longarón, R., Navarro, G., Salar, A., Espinet, B., Solé, F. G., Serrano, S., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404649 · Cited by 23
Screening of JAK2 V617F mutation in multiple myeloma
Fiorini, A., Farina, G., Reddiconto, G., Palladino, M., Rossi, E., Zà, T., Laurenti, L., Giammarco, S., Chiusolo, P., Leone, G. G. M., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404332 · Cited by 22
Absence of BRAF Gene Mutation in Non-Melanoma Skin Tumors
Libra, M., Malaponte, G., Bevelacqua, V., Siciliano, R., Castrogiovanni, P., Fulvi, A., Micali, G., Ligresti, G., Mazzarino, M. C., Stivala, F., et al. (2006) · Cell Cycle · doi:10.4161/cc.5.9.2724 · Cited by 21
Self-citationGenomic organization of human JAK2 and mutation analysis of its JH2-domain in leukemia
Cools, J., Peeters, P. J., Voet, T., Aventin, A. M., Mecucci, C., Grandchamp, B., & Marynen, P. (1999) · Cytogenetic and Genome Research · doi:10.1159/000015308 · Cited by 20
Vrana, J. A., Cleaveland, E. S., Eastman, A. R., & Craig, R. W. (2006) · APOPTOSIS · doi:10.1007/s10495-006-7787-y · Cited by 15
McCubrey, J. A., Shelton, J. G., Steelman, L. S., Franklin, R. A., Sreevalsan, T., & McMahon, M. (2004) · Oncogene · doi:10.1038/sj.onc.1208055 · Cited by 14
Self-citationJAK2 mutation in a boy with polycythemia vera, but not in other pediatric hematologic Disorders
Park, M.-J., Shimada, A., Asada, H., Koike, K., TSUCHIDA, M., & Hayashi, Y. (2006) · Leukemia · doi:10.1038/sj.leu.2404259 · Cited by 12
Desta, F. Z., Christiansen, D. H., Andersen, M. K., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404072 · Cited by 12
Cited by
Reactive oxygen species in cancer
Liou, G.-Y., & Storz, P. (2010) · Free Radical Research · doi:10.3109/10715761003667554 · Cited by 3,382
ROS signalling in the biology of cancer
Moloney, J. N., & Cotter, T. G. (2018) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2017.05.023 · Cited by 1,970
The Different Mechanisms of Cancer Drug Resistance: A Brief Review
Mansoori, B., Mohammadi, A., Davudian, S., Shirjang, S., & Baradaran, B. (2017) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2017.041 · Cited by 1,883
Reactive Oxygen Species: A Key Constituent in Cancer Survival
Kumari, S., Badana, A. K., G, M. M., G, S., & Malla, R. (2018) · Biomarker Insights · doi:10.1177/1177271918755391 · Cited by 777
Oxidative Stress in Cancer Cell Metabolism
Arfin, S., Jha, N. K., Jha, S. K., Kesari, K. K., Ruokolainen, J., Roychoudhury, S., Rathi, B., & Kumar, D. (2021) · Antioxidants · doi:10.3390/antiox10050642 · Cited by 665
Metadata
- Authors
- Steelman, L. S., Abrams, S. L., Whelan, J., Bertrand, F. E., Ludwig, D. E., Bäsecke, J., Libra, M., Stivala, F., Milella, M., Tafuri, A., Lunghi, P., Bonati, A., Martelli, A. M., & McCubrey, J. A.
- Venue
- Leukemia
- Published
- 2008-03-13
- Volume
- 22
- Issue
- 4
- Pages
- 686-707
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W1599602125
- Cited by
- 385
- References
- 333
- FWCI
- 20.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.